Cameco Balance Sheet Health
Financial Health criteria checks 4/6
Cameco has a total shareholder equity of CA$6.2B and total debt of CA$1.4B, which brings its debt-to-equity ratio to 22.9%. Its total assets and total liabilities are CA$9.3B and CA$3.1B respectively. Cameco's EBIT is CA$307.7M making its interest coverage ratio 5.6. It has cash and short-term investments of CA$197.1M.
Key information
22.9%
Debt to equity ratio
CA$1.42b
Debt
| Interest coverage ratio | 5.6x |
| Cash | CA$197.14m |
| Equity | CA$6.21b |
| Total liabilities | CA$3.08b |
| Total assets | CA$9.29b |
Recent financial health updates
No updates
Recent updates
Cameco: Strong Q3 Performance As Kazakh Output Falls Short
Nov 07Cameco: A Short-Term Dip Can Be The Perfect Buying Opportunity
Oct 28Cameco: My Stock Pick For This Decade, Here Is My Half-Decade Report
Oct 22Cameco: The Catalysts Are Nearly All In Place
Sep 26Cameco: Nuclear Industry Excitement Provides More Fuel, Services, And New Design Opportunities
Sep 18Cameco: A Nuclear Powerhouse Unleashed
Aug 25Cameco Corp. Q2 Results Better, But Shares Down Over The Last Month
Aug 11Cameco: AI And Politics Are Good For Business
Jul 08Cameco: Spanning The Uranium, Nuclear Value Chain With Favorable Growth Expectations
Jul 01Cameco Goes Nuclear
Jun 02Cameco: A Bullish Trend Set To Continue Despite Q1 Earnings
May 01Cameco: Upgrading To 'Buy' After Pullback, Strong Uranium Market
Mar 18Cameco Earnings: Outlook For 2024 Is Strong
Feb 12Cameco: Uranium Prices Are White Hot
Jan 11Cameco: Time To Book Some Profits
Dec 08Cameco's Promising Outlook: Riding The Wave Of The Uranium Resurgence
Oct 31Cameco: Nuclear's Bright Future Is Already Priced In
Sep 20Cameco: Bright Near-Term Outlook With Improving Market Fundamentals, 20% Upside
Sep 12Got Uranium? Why Cameco Remains Unstoppable
Sep 03Cameco: Keeps Adding To Its Contract Portfolio (Rating Downgrade)
Aug 18Cameco: First Half Results Robust, But The Stock Is Richly Priced
Aug 03Cameco: Digging For Precious Uranium Ore
Jul 19Cameco: Uranium Price In The Short Term, Nuclear Renaissance In The Long Term (Rating Upgrade)
Jun 20Cameco: Riding The Wave Of Positive Momentum In The Uranium Sector
Jun 13Cameco Q4 2022 Earnings Preview
Feb 08Cameco Is Now Well Positioned To Become A Significant Nuclear Supplier
Feb 02Cameco: 3 Catalysts For 2023
Jan 26Cameco: A Turnaround Is En Route
Jan 17Cameco: Changing Direction, Complicating The Bull Case
Nov 15Financial Position Analysis
Short Term Liabilities: CCJ's short term assets (CA$1.5B) exceed its short term liabilities (CA$527.9M).
Long Term Liabilities: CCJ's short term assets (CA$1.5B) do not cover its long term liabilities (CA$2.5B).
Debt to Equity History and Analysis
Debt Level: CCJ's net debt to equity ratio (19.7%) is considered satisfactory.
Reducing Debt: CCJ's debt to equity ratio has increased from 20.3% to 22.9% over the past 5 years.
Debt Coverage: CCJ's debt is well covered by operating cash flow (40.6%).
Interest Coverage: CCJ's interest payments on its debt are well covered by EBIT (5.6x coverage).